Get the Stockscreener App
1.33
0.76%
0.01
After Hours:
1.33
Bone Biologics Corp stock is traded at $1.33, with a volume of 18,295.
It is up +0.76% in the last 24 hours and up +10.83% over the past month.
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
See More
Previous Close:
$1.32
Open:
$1.35
24h Volume:
18,295
Relative Volume:
1.13
Market Cap:
$2.39M
Revenue:
-
Net Income/Loss:
$-3.11M
P/E Ratio:
-0.3327
EPS:
-3.9975
Net Cash Flow:
$-2.69M
1W Performance:
+1.92%
1M Performance:
+10.83%
6M Performance:
-30.37%
1Y Performance:
-66.92%
1-Day Range:
$1.33
$1.40
1-Week Range:
$1.29
$1.40
52-Week Range:
$1.05
$6.75
Bone Biologics Corp Stock (BBLG) Company Profile
Name
Bone Biologics Corp
Sector
Industry
Phone
(781) 552-4452
Address
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
1.33 | 2.37M | 0 | -3.11M | -2.69M | -3.9975 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Bone Biologics Corp Stock (BBLG) Latest News
Leading Companies Fueling Growth and Innovation in the Spine Biologics Market - openPR.com
BBLGW (Bone Bio) quarterly earnings release excludes core financial metrics, investors seek additional operational disclosures.Balance Sheet - Newser
Bone Bio (BBLG) Stock: Volatility Overview (-1.78%) 2026-04-23Crowd Sentiment Stocks - Newser
BBLGW (Bone Bio) quarterly earnings carry no finalized public metrics as the firm wraps up internal financial reviews.Community Sell Signals - Newser
BBLGW (Bone Bio) quarterly earnings data unavailable, stakeholders await updates on core orthobiologics growth plans.Community Chart Signals - Cổng thông tin điện tử Tỉnh Sơn La
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the Orthobiologics Market - openPR.com
Is First Mid (FMBH) stock still a good play today (Flirts with Breakout) 2026-04-20Social Investment Platform - Cổng thông tin điện tử tỉnh Lào Cai
Aug Weekly: What is Bone Biologics Corporation Equity Warrants revenue forecastExit Point & Fast Moving Market Watchlists - baoquankhu1.vn
Stock List: Research Stocks from Around the World - GuruFocus
Entry Recap: What is the Moat Score of Bone Biologics CorporationQuarterly Performance Summary & Consistent Return Strategy Ideas - baoquankhu1.vn
Biocon Announces U.S. Commercial Launch of Bosaya™ and Aukelso™, Denosumab Biosimilars - PharmiWeb.com
Is Bel Fuse (BELFB) Stock at a Peak | Price at $204.62, Down 0.01%Community Driven Stock Picks - Cổng thông tin điện tử tỉnh Lào Cai
BBLGW Stock Analysis: Bone Biologics Corp Warrants Flat at 21 Amid Calm Biotech Trading - Cổng thông tin điện tử tỉnh Tây Ninh
Market Structure, Emerging Trends, and Key Player Analysis in the Orthobiologics Devices and Equipment Sector - openPR.com
Earnings Update: Whats the profit margin of Aptiv PLC2026 Rallies & Capital Protection Trading Alerts - baoquankhu1.vn
TPB Stock Analysis: Turning Point Brands Inc drops 14.45% to 74.25 in selloff - Cổng thông tin điện tử tỉnh Lào Cai
Exit Recap: Is Bone Biologics Corporation a strong candidate for buy and holdEarnings Risk Summary & Low Risk Entry Point Guides - baoquankhu1.vn
Global Drivers Analysis: Factors Behind the Rapid Evolution of the Demineralized Bone Matrix Market - openPR.com
What technical signals show for Corporacion (VTMX) Stock | Price at $35.54, Up 0.11%ATR Levels - Cổng thông tin điện tử tỉnh Lào Cai
Aug PostEarnings: Is INNOVATE Corp a top pick in the sector2026 Valuation Update & Weekly High Conviction Ideas - baoquankhu1.vn
Competitive Analysis: Leading Companies and New Entrants in the Bone Graft Fixation System Market - openPR.com
Gains Report: What is the implied volatility of Bone Biologics Corporation Equity Warrant2026 Selloffs & Capital Protection Trade Alerts - baoquankhu1.vn
Aug Sentiment: Is Bone Biologics Corporation stock a good pick for beginners2026 Analyst Calls & Weekly Top Performers Watchlists - baoquankhu1.vn
Downgrade Watch: Is BCPC likely to announce a buyback2026 Key Highlights & Daily Profit Maximizing Tips - baoquankhu1.vn
If You Invested $1,000 in Bone Biologics Corp (BBLG) - Stock Titan
BBLG Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Market Leaders: Can Bone Biologics Corporation Equity Warrant sustain its profitability2026 Snapshot & Weekly Stock Performance Updates - baoquankhu1.vn
Bone Biologics Corporation Announces $1 Million At-the-Market Offering of Common Stock Through H.C. Wainwright & Co - Minichart
Bone Biologics launches $1.06 million at-the-market offering on Nasdaq - Investing.com
Bone Biologics launches $1.064M at-the-market equity program via H.C. Wainwright - TradingView
Bone Biologics (NASDAQ: BBLG) adds $1.064M at-the-market stock capacity - Stock Titan
Bone Biologics (NASDAQ: BBLG) launches $1.06M ATM sale with Wainwright - Stock Titan
8-K: Current report - Moomoo
BBLG PE Ratio & Valuation, Is BBLG Overvalued - Intellectia AI
Aug Movers: What is Bone Biologics Corporation Equity Warrant s revenue forecastGlobal Markets & Entry Point Strategy Guides - baoquankhu1.vn
Trading Action: Does NVFY stock benefit from AI growthPortfolio Value Summary & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Treasury Yields: Is InMode Ltd a top pick in the sector2025 Top Decliners & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Surprises Report: Is Bone Biologics Corporation Equity Warrant still a buy after recent gainsJuly 2025 Outlook & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Bone Biologics FY2026 EPS Forecast Reduced by Zacks Research - Defense World
Aug Technicals: What is Bone Biologics Corporations valuation compared to sectorJuly 2025 Catalysts & Trade Opportunity Analysis Reports - baoquankhu1.vn
Brokers Issue Forecasts for Bone Biologics Q1 Earnings - Defense World
Aug Summary: Will IBEX outperform during market rallies2025 Geopolitical Influence & Reliable Price Action Trade Plans - baoquankhu1.vn
BBLG Technical Analysis & Stock Price Forecast - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
BBLG Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BBLG Financials Show Company in Solid Shape - Yahoo Finance
getLinesFromResByArray error: size == 0 What sentiment indicators say about Bone Biologics Corporation Equity Warrant stockIndex Update & Reliable Intraday Trade Alerts - mfd.ru
Bone Biologics (NASDAQ: BBLG) flags going concern and limited cash runway - Stock Titan
Bone Biologics 10-K: Operating loss $3.23M, net loss $3.11M; EPS impact noted - TradingView
New fibroblast cell therapy patent targets osteoporosis - Stock Titan
Bone Marrow Aspirate Concentrates Market: Competitive - openPR.com
Bone Biologics Corp Stock (BBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.77%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):